GlaxoSmithKline settles lawsuit with claimant who alleged that its blockbuster heartburn medication Zantac caused his cancerBy Daily Mail City &...
GSK
GSK spin-off Haleon's shares dip as profits miss forecasts and health giant's margins are squeezed by higher costsEarnings per share...
BUSINESS LIVE: Standard Chartered profits soar; GSK beats forecasts thanks to shingles vaccine; Persimmon lifts housebuilding expectationsBy Live Commentary Published:...
Haleon dives after posting first set of full-year results since spin-off from drugs giant GSKBy Daily Mail City & Finance...
As a pure life sciences group, there is much more visibility for GlaxoSmithKline’s (GSK) drugs pipeline. As strongly as it...
Shingles jab sales record a shot in the arm for GSK: UK pharma giant predicts strong growth for 2023By Calum...
BUSINESS LIVE: GSK sales boosted by shingles drug; Entain lifts profit forecast; Vodafone flags European revenue growth slowdownBy Live Commentary...
GSK chooses West End for new HQ in a vote of confidence for London's status as a science hubBy Daily...
Zantac ruling is a shot in the arm for GSK: US judge rules heartburn drug cancer claims are based on...
Blow for GSK boss as pharma giant's blood cancer drug Blenrep fails to beat rival treatments in US testsBy Daily...